Department of Insurance Issues First-Ever GLP-1 Report
While utilization rises, rebates mean that insurers and employers break-even Use of GLP-1s – the popular medications to treat Type 2 Diabetes and obesity – nearly doubled among Delaware’s fully-insured commercial members from 2020 to 2023, according to a new first-in-the-nation analysis from the Department of Insurance’s Office of Value-Based Health Care Delivery. Data shows […]
CONSUMER ALERT: Patient And Pharmacy Protections During Rite Aid Closures
Navarro issues bulletin regarding consumer access, coverage, other insurer and PBM requirements Rite Aid has commenced Chapter 11 bankruptcy proceedings, resulting in pharmacy closures in Delaware. These closures may disrupt patient access to medications, making prescription transfers and pharmacy accommodations an urgent priority. Insurance Commissioner Trinidad Navarro issued Bulletin No. 153 in response, building upon […]
Navarro Announces Completion of First Pharmacy Benefit Manager Exams
Efforts to protect consumers and independent pharmacies, and lower pharmaceutical costs continue Following the unanimous passage of legislation in 2021, the Delaware Department of Insurance was given regulatory authority over Pharmacy Benefit Managers (PBMs) and has been building an investigation and enforcement program in order to address the multi-billion-dollar industry that has played a key […]
General Assembly Moves in Unison to Protect Consumers, Local Businesses, from Excessive Pharmaceutical Costs
Expanded oversight of Pharmacy Benefits Managers possible Legislation to further regulate the Pharmacy Benefits Manager industry was passed by the General Assembly in late June and sent to the Governor with unanimous bipartisan support. HB 219, sponsored by Rep. Andria Bennett, Sen. Spiros Mantzavinos, Senate President Pro Tempore Dave Sokola, and Rep. Mike Smith, would […]
DNREC to Hold Pharmaceutical Rule Training Webinar
The Delaware Department of Natural Resources and Environmental Control will host a training webinar Tuesday, June 22 to provide guidance for the state’s Pharmaceutical Rule adopted in January 2021, addressing changes to management standards for hazardous waste pharmaceuticals, as well as changes to the U.S. Environmental Protection Agency’s Final Rule P075 listing for nicotine waste.
